UNSPSC 51102911: Artesunate/Pyronaridine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class AP101. This VA Drug Class (AP101) classifies this compound as belonging to the group ANTIMALARIALS.

UNSPSC 51102911 Artesunate/Pyronaridine is a Commodity code that, in state and local procurement records, shows minimal recent activity directly aligned with its nominal scope. The two most recent opportunities tagged to this code involve unrelated pharmaceutical products: the Illinois Department of Public Health's award to Chartwell Rx LLC for Doxycycline Hyclate 100mg and Ciprofloxacin Hydrochloride 500mg tablets through the MMCAP Infuse cooperative purchasing vehicle, and Seminole County, Florida's procurement of Naloxone and Drug Deactivation Systems for community health support. Neither opportunity involves artesunate or pyronaridine, antimalarial or antiparasitic agents, suggesting either broad tagging misapplication by issuing bodies or that state and local procurement under this code does not currently reflect its intended commodity scope.

The geographic footprint of recent activity spans Illinois and Florida based on the available records, with the Illinois award representing a completed contract for $2,999,999.11 over the full term (12 months plus two renewal years) through an Invitation for Bid process, while the Seminole County opportunity, posted June 30, 2026 with a response deadline of July 26, 2026, sought annual volumes of 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems with quarterly deliveries. State and local procurement under this code warrants close monitoring for misclassified opportunities, and direct pursuit should focus on health departments and counties where antimalarial or antiparasitic pharmaceutical procurement is documented separately.